Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1626 1673 1693 1699
This examiner grants 53% of resolved cases
Ganapathy Krishnan is an examiner in Tech Center 1600 and Art Unit 1623. The examiner has a high volume of 1122 resolved cases, which provides a very reliable dataset for analysis. The allowance rate for these cases is 52.7 percent, indicating a rigorous examination process where about half of the applications result in a grant. Practitioners can use the 52.7 percent allowance rate to assess the general receptivity of the examiner to patent applications in this art unit.
The median days to allowance is 1149, reflecting the typical speed of prosecution from filing to issuance. The data also shows an interview lift of 1.0 percent, which is very low. This 1.0 percent lift suggests that interviews have a minimal impact on the likelihood of allowance with this examiner. Practitioners should focus on the quality of their written submissions, as the 1122 resolved cases show that the 52.7 percent allowance rate is largely independent of verbal communication. The 1149-day median pendency remains a key metric for planning purposes.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18005988 | NANOCELLULOSE SUPPORT AND METHOD FOR PRODUCING SAME | Final Rejection | LG ELECTRONICS INC. |
| 18542778 | CELLULOSE PARTICLES AND METHOD FOR PRODUCING CELLULOSE PARTICLES | Non-Final OA | FUJIFILM Business Innovation Corp. |
| 18378404 | OMEGA-3 FATTY ACID AND VITAMIN D LEVELS TO IDENTIFY AND ATTENUATE COGNITIVE AGING IN INDIVIDUALS | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18284318 | COMPOSITION COMPRISING CELLULOSE NANOFIBER AND LIGNIN OR COMPLEX OF THESE COMPONENTS, AND METHOD FOR PRODUCING LIGNOCELLULOSE-DERIVED MATERIAL | Final Rejection | Yokogawa Electric Corporation |
| 18452831 | POLYMER THIN FILM FOR CAPTURING AND RELEASING NUCLEIC ACID WITH HIGH EFFICIENCY AND METHOD FOR EXTRACTING NUCLEIC ACID USING THE SAME | Final Rejection | Korea Advanced Institute of Science and Technology |
| 18645671 | COMPOUNDS AND METHODS FOR TREATMENT OF VIRAL INFECTIONS | Non-Final OA | Gilead Sciences, Inc. |
| 18535483 | COMPOSITIONS OF ASCORBIC ACID SALTS | Final Rejection | SHISEIDO COMPANY, LTD. |
| 18471821 | COMPOSITION FOR IMPROVING THE SOLUBILITY OF POORLY SOLUBLE SUBSTANCES, COMPLEX FORMULATION AND LIQUID FORMULATION OF AN ACTIVE INGREDIENT | Final Rejection | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE |
| 17434442 | Purification Process for Biological Molecules Such as Plasmid DNA Using Anionic Exchange Chromatography | Non-Final OA | Lonza Ltd |
| 17864828 | Delivery of Active Agents | Final Rejection | MannKind Corporation |
| 18561644 | METHODS OF TREATING MEDICAL CONDITIONS AND INHIBITING LINE1 REVERSE TRANSCRIPTASE USING A SUBSTITUTED 4-FLUORO-2,5-DIHYDROFURANYL PHOSPHONIC ACID OR RELATED COMPOUND | Non-Final OA | ROME Therapeutics, Inc. |
| 17757453 | INJECTABLE MIXTURES OF HYALURONIC ACID FOR USE IN DERMO-AESTHETICS | Final Rejection | Altergon S.A. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy